LTR Net Debt from 2010 to 2026

Stocks Australia . 
Stock . LTR Pharma
LTP Stock   0.49  0.02  3.92%   
LTR Pharma Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt will likely drop to about 170.7 K in 2026. Net Debt is the total debt of LTR Pharma minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
192 K
Current Value
170.7 K
Quarterly Volatility
11.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check LTR Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LTR Pharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 98.8 K or Interest Expense of 361, as well as many indicators such as . LTR financial statements analysis is a perfect complement when working with LTR Pharma Valuation or Volatility modules.
  
This module can also supplement various LTR Pharma Technical models . Check out the analysis of LTR Pharma Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for LTR Stock Analysis

When running LTR Pharma's price analysis, check to measure LTR Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LTR Pharma is operating at the current time. Most of LTR Pharma's value examination focuses on studying past and present price action to predict the probability of LTR Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LTR Pharma's price. Additionally, you may evaluate how the addition of LTR Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY